Phosphorylation of calmodulin: Functional implications by Benaim, Gustavo & Villalobo, Antonio
REVIEW ARTICLE
Phosphorylation of calmodulin
Functional implications
Gustavo Benaim1 and Antonio Villalobo2
1Instituto de Biologı´a Experimental, Facultad de Ciencias, Universidad Central de Venezuela, Caracas, Venezuela;
2Instituto de Investigaciones Biome´dicas, Consejo Superior de Investigaciones Cientı´ﬁcas and Universidad
Auto´noma de Madrid, Spain
Calmodulin (CaM) is phosphorylated in vitro and in vivo
by multiple protein-serine/threonine and protein-tyrosine
kinases. Casein kinase II and myosin light-chain kinase
are two of the well established protein-serine/threonine
kinases implicated in this process. On the other hand,
within the protein-tyrosine kinases involved in the phos-
phorylation of CaM are receptors with tyrosine kinase
activity, such as the insulin receptor and the epidermal
growth factor receptor, and nonreceptor protein-tyrosine
kinases, such as several members of the Src family kinases,
Janus kinase 2, and p38Syk. The phosphorylation of
CaM brings important physiological consequences for
the cell as the diverse phosphocalmodulin species have
diﬀerential actions as compared to nonphosphorylated
CaM when acting on diﬀerent CaM-dependent systems.
In this review we will summarize the progress made on
this topic as the ﬁrst report on phosphorylation of CaM
was published almost two decades ago. We will empha-
size the description of the phosphorylation events medi-
ated by the diﬀerent protein kinases not only in the test
tube but in intact cells, the phosphorylation-mediated
changes of CaM activity, its action on CaM-dependent
systems, and the functional repercussion of these phos-
phorylation processes in the physiology of the cell.
Keywords: calmodulin; calmodulin-dependent systems;
cellular signalling; phosphocalmodulin; protein kinases;
phosphoprotein phosphatases.
I N T R O D U C T I O N
Calmodulin as a Ca2+ sensor
The average cytosolic concentration of free Ca2+ in
resting cells ranges from 20 to 50 nM, reaching values
close to 1 lM when the cell is stimulated by a variety of
physiological stimuli, while in the extracellular milieu this
concentration is about 1 mM. This large concentration
gradient allows intracellular Ca2+ to work as an useful
second messenger [1,2]. The cytosolic Ca2+ concentration
is exquisitely regulated by the operation of transport
systems responsible for its increase, represented by different
types of Ca2+ channels and Na+(H+)/Ca2+ exchangers
located in the plasma membrane, the endo(sarco)plasmic
reticulum, and/or the mitochondria; and extrusion trans-
port systems represented by Ca2+-ATPases located in both
the plasma membrane and the endo(sarco)plasmic reticu-
lum, and the Na+/Ca2+ exchanger also located within the
plasma membrane [1,3]. The operation of theses transport-
ers gives rise to oscillations in the concentration of Ca2+ not
only in the cytosol but in the nucleus and intracellular
organelles [1,4,5]. It has been possible to observe in living
cells inhomogeneities in these transient changes in
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Ca2+ concentration represented by singular events of
progressively higher magnitudes which generate global
changes modulated both in amplitude and frequency
[6–8]. Free Ca2+ regulates multiple cellular functions, and
the role of Ca2+ as an intracellular messenger depends in
great extent on the existence of Ca2+-binding proteins
capable of decoding very small changes in its intracellular
concentration [1,3].
Calmodulin is an ubiquitous highly conserved acidic
Ca2+-binding protein present in all eukaryotic organisms
ranging from mammals to unicellular protists [9,10]. The
tertiary structure of CaM has been elucidated, presenting a
dumb-bell shape formed by two globular clusters at its
C- and N-termini that are connected by a ﬂexible central
ahelix [11] (Fig. 1). The interaction of CaM with its targets
occurs due to the Ca2+-induced increase in its ahelix
contents and the exposure of hydrophobic amino-acid
residues. The function of CaM is not conﬁned to its Ca2+-
bound form as it can recognize different protein targets as
apocalmodulin [10,12].
Calmodulin has been implicated in a myriad of cellular
processes, ranging from the synthesis and degradation of
cyclic nucleotides and phosphoinositides, the phosphoryla-
tion/dephosphorylation cycle of proteins, gene transcrip-
tion, and the regulation of different transport systems. This
pluripotential intracellular Ca2+ sensor hence regulates
crucial signalling pathways that are involved, among others,
in the control of cellular metabolism, cytoskeletal organ-
ization, cytokinesis, muscle contraction, osmotic cell volume
regulation, endo- and exocytosis, zygote fertilization, inter-
cellular communication, cell proliferation, differentiation,
and apoptosis [1,3,9,10].
Posttranslational modifications of calmodulin
As it would be expected for a protein of such a
paramount importance, CaM is susceptible to undergo
post-translational modiﬁcations. In addition to the acetyl-
ation of its N-terminal alanine [13], process which is
catalysed by an acetyltransferase, one of the most notable
post-translational modiﬁcations in mammalian CaM is the
trimethylation of its Lys115 catalysed by a calmodulin
(lysine) N-methyltransferase [13,14]. The dimethylation of
Lys13 in CaM from Paramecium has also been described
[15]. In addition, mammalian CaM is able to undergo
carboxylmethylation catalysed by a carboxylmethyltransf-
erase using S-adenosyl-L-methionine as donor of methyl
groups [14]. Nevertheless, the function of all these
methylation processes remains unclear. Another interest-
ing post-translational modiﬁcation of CaM is the proteo-
lytic cleavage of its C-terminal lysine residue, which is
mediated by a carboxypeptidase [14].
In any event, protein phosphorylation is by far the
most common mechanism of protein modiﬁcation aimed
to regulate cellular functions. The existence of multiple
well-regulated protein kinases and phosphoprotein phos-
phatases in all cells guarantees the occurrence of these
reversible phosphorylations. Therefore, it is not surpri-
sing that CaM actions were subjected to phosphoryla-
tion-dependent modulation. In this respect, mammalian
CaM possesses several putative phosphorylatable amino-
acid residues, which includes four serine, 12 threonine
and two tyrosine, some of which have been shown
indeed to be phosphorylated. Figure 1 shows in the
three-dimensional structure of human CaM the location
Fig. 1. Amino-acid residues of calmodulin
known to be phosphorylated by diﬀerent protein
kinases. The amino-acid residues phosphoryl-
ated by protein-serine/threonine kinases and
protein-tyrosine kinases are highlighted (yel-
low colour) in a tridimentional wire-frame
model of human CaM in its Ca2+-bound
conformation. The ﬁgure was prepared from
its reported crystallographic structure [82]
using the Cn3D 3.0 program. The three-letter
amino-acid code is used to label the targeted
residues indicated by numbers. Notice the
location of Thr79 and Ser81 in the central
a-helix, the location of Thr29, Tyr99 and
Ser101 in diﬀerent Ca2+-binding pockets, and
the greater exposure of Tyr99 as compared to
Tyr138.
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of the most relevant amino-acid residues on which
phosphorylation by different protein-serine/threonine
kinases and protein-tyrosine kinases have been demon-
strated. Figure 2 summarizes the protein kinases in-
volved and Table 1 shows the extent of these
phosphorylations.
Early evidence for calmodulin phosphorylation
About three decades ago, it was initiated the isolation of
a series of low molecular mass Ca2+-binding phospho-
proteins some of which, although presented properties
that not always matched those of CaM [16–18], were
able to activate typical CaM-dependent enzymes, such as
cyclic nucleotide phosphodiesterase and adenylate cyclase
[19,20]. These observations opened the debate on the
possibility that CaM could be a phosphoprotein. That
discussion was temporally set aside when CaM, the
genuine activator of those enzymes, was puriﬁed and
shown in those days to lack covalently bound phos-
phate. Ten years later the situation was reversed when
the ﬁrst strong evidence for the existence of phosphor-
ylated CaM in chicken tissues was published by Plancke
and Lazarides [21]. Since then, the accumulated evidence
for CaM phosphorylation has grown and it has been
ﬁrmly consolidated. The goal of the present review is to
discuss the phosphorylation of CaM by different protein
kinases, to discern how these phosphorylations affect
its biological activity when acting on different CaM-
dependent systems, and to uncover the possible func-
tional implications of these phosphorylation processes in
living cells.
Fig. 2. Protein kinases known to phosphorylate
calmodulin. The protein-tyrosine kinases and
protein-serine/threonine kinases known to
phosphorylate calmodulin are shown in a
cartoon representing a cell. Jak2 is represented
to be associated to a CKR.
Table 1. Phosphorylation sites of calmodulin. Phosphorylated residues of mammalian CaM are represented by the three-letter amino-acid code.
Minority phosphorylations are indicated in parenthesis and expressed in percentage when known.
Protein kinase Phosphorylated residues References
Serine/threonine kinases
CK-II Thr79, Ser81, Ser101 (Thr117) [23,28–31]
MLCK Thr29 (Thr26, 10%) [34]
Tyrosine kinases
InsR Tyr99 (Tyr138, 33%) [31,39,49]
EGFR Tyr99 (Tyr138, 15%) [54,56,57]
c-Src Tyr99 (Tyr138, 26%) Unpublisheda
PTK-III (c-Fyn + c-Fgr) Tyr99 (Tyr138, 10%) [23,62]
a Salas, V., Benaim, G. & Villalobo, A, unpublished results.
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P H O S P H O R Y L A T I O N O F C A L M O D U L I N
B Y P R O T E I N - S E R I N E / T H R E O N I N E
K I N A S E S
The large number of protein-serine/threonine kinases pre-
sent in the cell are involved in many cellular functions as
they intervene in multiple signalling pathways and regula-
tory control systems. So far, only casein kinase II and
myosin light-chain kinase have been shown to phosphory-
late CaM within this group of protein kinases (Fig. 2).
Casein kinase II
The ﬁrst report on phosphorylation of CaM by CK-II did
not describe the need for basic polycations [22]. The
requirement for these basic cofactors was subsequently
found using a variety of positively charged molecules [23–
25]. Thereafter, all reports dealing with CaM phosphory-
lation by CK-II included basic polycations in the assay
systems used. The action of polycations appears to be more
complex than expected, as these agents activate CK-II
independently of its interaction with CaM. Moreover, the
phosphorylation state of the catalytic a subunit of CK-II
and the inhibitory action of its regulatory b subunit play
important roles in the phosphorylation process [24–27].
Conﬂicting early reports were published on the phos-
phorylation sites of CaM by CK-II in vitro. Hence, some
authors indicated that the major phosphorylation sites were
Ser81 and Thr79 [23], while others reported phosphoryla-
tion at Ser101 and Thr79, but not at Ser81 [28]. More
recently, phosphorylation of the three mentioned amino-
acid residues, plus a limited phosphorylation of Thr117, has
been reported [29–31] (Fig. 1). Moreover, as CaM isolated
from rat liver has been shown to be phosphorylated at
Thr79, Ser81 and Ser101, this gives support to the notion
that CK-II may phosphorylate the three mentioned residues
in vivo [30] (Table 1).
Thr79 and Ser81 are located in the central ahelix of
CaM, a region of great importance for its interaction with
target CaM-dependent proteins. In contrast, Ser101 is
located in its third Ca2+-binding pocket (Fig. 1). Thus,
phosphorylation of these residues may affect the interaction
of CaM with target proteins and/or its Ca2+ binding
capacity. Indeed, it was demonstrated that the phosphory-
lation of CaM by CK-II increases the binding afﬁnity for
Ca2+ as compared with nonphosphorylated CaM by the
use of Tb3+ as an analogue of Ca2+ [32]. In contrast, a
subsequent report using ﬂow dialysis showed that phos-
phorylation of CaM by CK-II slightly decreases its afﬁnity
for Ca2+ [33]. It is interesting to mention in this context that
the presence of Ca2+ at low concentrations stimulates the
phosphorylation of CaM by CK-II [24], while higher
concentrations inhibit this process, particularly affecting
the phosphorylation of serine residues [23,24].
Myosin light-chain kinase
Chicken gizzardMLCKphosphorylates CaM in vitro in the
presence of poly(L-arginine) [34]. In contrast to its phos-
phorylation by other protein kinases, Ca2+ stimulates this
process in a biphasic manner, reaching a maximum at
50 lM [34]. This phosphorylation takes place predominantly
at Thr29, located in the ﬁrst Ca2+-binding site of CaM
(Fig. 1), although a limited phosphorylation of Thr26 was
also observed [34] (Table 1). Using different CaM mutants,
it was demonstrated that the duplication of the N-terminal
EF-hand pair, or switching the C- and N-terminal EF-hand
pairs, increases its phosphorylation as compared to wild
type CaM. A CaM mutant with a duplicated C-terminal
EF-hand pair was not phosphorylated [35]. These results
suggest that the orientation of the different Ca2+-binding
pockets of CaM can be distinguished by MLCK [35].
Other protein-serine/threonine kinases
The phosphorylation of endogenous and exogenous CaM
by a crude preparation of skeletal muscle phosphorylase
kinase has been reported [21]. However, other authors failed
to detect phosphorylation of exogenously added CaM by
this kinase [23]. This could be due to a very low
phosphorylation stoichiometry, as its value was reported
to be 0.01 mol of phosphate incorporated per mol of CaM
[21], what may rest physiological signiﬁcance to this
observation. Additional protein-serine/threonine kinases
have been tested for their capacity to phosphorylate CaM.
This included protein kinase C, cyclic AMP-dependent
protein kinase and casein kinase I, and it was shown that all
these kinases were unable to phosphorylate CaM in vitro
[22,23].
P H O S P H O R Y L A T I O N O F C A L M O D U L I N
B Y P R O T E I N - T Y R O S I N E K I N A S E
R E C E P T O R S
Of the 50+members in the superfamily of protein-tyrosine
kinase receptors, only the insulin receptor and the epidermal
growth factor receptor have been shown to phosphorylate
CaM (Fig. 2).
Insulin receptor
The insulin-dependent phosphorylation of CaM by the
InsR isolated from different sources such as adipose tissue,
liver, skeletal muscle, and placenta has been described [36–
42]. This phosphorylation requires the presence of diverse
polycations or basic proteins to be optimal, such as poly
(L-lysine), protamine or histone [40]. These cofactors have a
concentration-dependent biphasic behaviour, thus present-
ing a stimulatory phase at low concentrations and an
inhibitory effect at higher concentrations [38,42,43]. The
mode of action of the polycations is heterogeneous. Thus, in
experiments using poly(L-lysine), it was demonstrated that
although the formation of a poly(L-lysine)/calmodulin
complex appears to be an essential factor for the phos-
phorylation to occur [42,43], poly(L–lysine) itself directly
activates the tyrosine kinase activity of the InsR by an
insulin-independent mechanism [42,44].
The search for cofactors that may work in physiological
conditions increasing the phosphorylation of CaM is
undoubtedly a topic of great interest. In this context, it
has been proposed that the C-terminal region of K-Ras,
but not of N-Ras, may play this role, as a peptide
corresponding to this highly basic segment of K-Ras
stimulates the phosphorylation of CaM by the insulin
receptor [45,46]. This observation could be related to the
observed interaction of CaM with K-Ras, but not with
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N-Ras or H-Ras [47]. The phosphorylation of CaM by
the InsR is sensitive to Ca2+, as concentrations above
1–10 lM progressively inhibit this process [37,40–42,45,48],
while lower concentrations appear to have a signiﬁcant
stimulatory effect [37].
Earlier reports on the phosphorylation of CaM by the
InsR showed very low stoichiometry, in the order of 0.01–
0.15 mol of phosphate incorporated per mol of CaM [38–
40]. Subsequent improvement in the assay conditions
increased the observed stoichiometry to values close to 1
(mol/mol) [42,49]. The phosphorylation of CaM by isolated
InsR preparations takes place at tyrosine residues, with little
phosphorylation at serine, process that is mediated by
contaminant protein-serine/threonine kinase(s) [36,40]. The
information available on the actual tyrosine residues that are
phosphorylated by this receptor is not homogeneous.
Hence, some reports indicated that the phosphorylation
took place only or predominantly at Tyr99 [38,43,50], while
others demonstrated that this phosphorylation occurred at
Tyr99 and Tyr138 [31,39,49] (Table 1 and Fig. 1). The
detection of signiﬁcant phosphorylation at Tyr138 was
favoured by the use of more sophisticated analytical
techniques, such as the assay of a CaM mutant that lacks
Tyr99 or by sequence analysis of CaM phosphopeptides
[31,39,49]. The typical Ca2+-induced electrophoretic mobil-
ity shift of nonphosphorylated CaM was absent or of little
magnitude in CaM phosphorylated by the InsR [38,50].
Interestingly, the InsR increased its ability to phosphorylate
CaM that was previously phosphorylated by CK-II [29].
Epidermal growth factor receptor
An early short report showed that plasma membrane
fractions from A431 tumour cells, a cell line that over-
expresses the EGFR, phosphorylate CaM in an EGF-
stimulated manner [51]. This phosphorylation occurred
exclusively at serine residues [51], therefore excluding the
EGFR as the direct actor in this process. Thereafter, it was
demonstrated that the EGFR isolated from rat liver by
CaM-afﬁnity chromatography was able to phosphorylate
CaM at tyrosine residues in the presence of polycations as
cofactors with a stoichiometry close to 1 (mol/mol) [52–55].
The basic cofactors used, poly(L-lysine) and histone, present
also biphasic effects. Thus, the observation of an optimal
polycation/calmodulin molar ratio to attain maximum
phosphorylation of CaM was a prominent feature of this
process [54]. This phosphorylation takes place essentially at
Tyr99, with only residual phosphorylation of Tyr138 if any
[54,56,57] (Table 1 and Fig. 1). It is interesting to mention
that in contrast to CaM phosphorylated by the InsR, CaM
phosphorylated by the EGFR presents a Ca2+-induced
electrophoretic mobility shift identical to nonphosphory-
lated CaM [54], underscoring the different nature of these
P-CaM species, particularly in its relative proportion of
Tyr99 and Tyr138 phosphorylation (Table 1).
We have also demonstrated that exogenous CaM can be
phosphorylated in an EGF-dependent manner after enter-
ing into permeabilized transfected murine ﬁbroblasts over-
expressing the human EGFR with similar characteristics
than those produced by its phosphorylation with the
isolated receptor from rat liver [58]. Calcium ion has a very
pronounced inhibitory effect on CaM phosphorylation,
exhibiting a K¢i below 1 lM [54,58]. This is particularly
important, as the cytosolic Ca2+ rise generated by the
activation of the EGFR in intact cells is of a magnitude
compatible with the transient prevention of the EGF-
dependent phosphorylation of CaM at this point of the
receptor activation cycle [59].
P H O S P H O R Y L A T I O N O F C A L M O D U L I N
B Y N O N R E C E P T O R P R O T E I N - T Y R O S I N E
K I N A S E S
Several nonreceptor protein-tyrosine kinases has been
shown to phosphorylate CaM including several members
of the Src family, and other nonrelated kinases such as Jak2
and p38Syk (Fig. 2).
Src family kinases
A viral variant of Src isolated from cells transformed by
the Rous sarcoma virus was the ﬁrst nonreceptor protein-
tyrosine kinase identiﬁed to phosphorylate CaM [60]. The
phosphorylation of CaM by isolated v-Src was measured
in the absence of added polycations, and this phosphory-
lation was inhibited by Ca2+ with a K¢i of 30 lM [60].
This value is signiﬁcantly higher than the one described
for the phosphorylation of CaM by the EGFR [54,58].
We have observed, however, that addition of poly
(L-lysine) strongly stimulates the phosphorylation of
CaM by puriﬁed c-Src (V. Salas, G. Benaim &
A. Villalobo, unpublished results), the normal nontumori-
genic form of this kinase. Moreover, this phosphorylation
takes place at Tyr99, and to a lesser but signiﬁcant extent
at Tyr138 (Table 1 and Fig. 1). In agreement with the
expected proportionally high phosphorylation of Tyr138,
the P-CaM species resulting from the catalysis by v-Src
has a slower electrophoretic mobility than native non-
phosphorylated CaM [60].
Other protein-tyrosine kinases of the Src family have
been tested for their capacity to phosphorylate CaM with
mix results. Thus, PTK-III from spleen, a preparation
containing c-Fyn plus c-Fgr [61], efﬁciently phosphorylates
CaM in the presence of different polycations, preferentially
at Tyr99, although phosphorylation at Tyr138 was also
detected [23,62] (Table 1 and Fig. 1). In contrast, it was
shown that PTK-I/c-Lyn, and PTK-IIA (also related to
c-Lyn) isolated from the same source fail to phosphorylate
CaM [23].
Janus kinase 2
Little information is available about the phosphorylation
of calmodulin by the Janus kinase family. Thus, there is
only a report describing that a puriﬁed preparation of
Jak2 coupled to agarose beads and isolated from a cell
line derived from inner medullar collecting ducts from
kidney was able to phosphorylate CaM in a time-
dependent manner in the absence of added polycations
[63].
Other nonreceptor protein-tyrosine kinases
A few additional nonreceptor protein-tyrosine kinases have
been tested for their ability to phosphorylate CaM. The
protein-tyrosine kinase PTK-IIB/p38Syk from spleen is not
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related to Src but to p72Syk. Interestingly, this kinase has
been shown to phosphorylate CaM in the presence of
polycations, albeit at a very low rate [23]. In contrast, c-Abl,
a cellular homologue of the tumorigenic gene product from
Abelson murine leukaemia virus, fails to phosphorylate
CaM [23].
P H O S P H O R Y L A T I O N O F C A L M O D U L I N
B Y U N I D E N T I F I E D P R O T E I N K I N A S E S
Phosphorylation of CaM tightly bound to puriﬁed rat liver
plasma membrane fractions by unidentiﬁed membrane-
bound protein kinases has been described previously [64,65].
This phosphorylation was inhibited by Ca2+, does not
require the addition of exogenous polycations and takes
place exclusively at serine residues [64,65]. In contrast, the
phosphorylation of exogenous CaM by these plasma
membrane preparations requires the presence of polycations
presenting a biphasic behaviour toward the polycation/
calmodulin (mol/mol) ratio, and takes place at serine,
threonine plus tyrosine residues [65]. The phosphorylation
of exogenous CaM was more sensitive to the inhibitory
action of Ca2+ than that of endogenous CaM, presenting a
K¢i of 1 lM by the former and higher than 0.1 mM by the
latter [65]. The differential phosphorylation of endogenous
and exogenous CaM by protein kinases associated to the
plasma membrane is an interesting observation, as under-
scores that both P-CaM pools could have different
functions in the cell. Plasma membrane fractions isolated
fromEhrlich ascites tumour cells lack boundCaMalthough
contain protein kinase(s) able to phosphorylate exogenously
added CaM in the presence of polycations [65]. CaM was
also phosphorylated in the presence of polycations by
cytosolic preparations from the inner and outer zones of the
adrenal cortex [66]. This latter phosphorylation took place
with low stoichiometry, was inhibited byCa2+ and occurred
exclusively at threonine residue(s) [66].
P H O S P H O R Y L A T I O N O F C A L M O D U L I N
I N I N T A C T C E L L S A N D T I S S U E S
The ﬁrst strong evidence for the existence of P-CaM in vivo
was obtained from chicken brain and muscle, where CaM
phosphorylated exclusively at serine residues was identiﬁed
as amajor component of these tissues [21]. Interestingly, this
P-CaM species does not present the Ca2+-induced elec-
trophoretic mobility shift observed in nonphosphorylated
CaM [21]. Thereafter, P-CaM was isolated from rat brain,
where it appears to be more prevalent in its particulate
fraction than in its soluble fraction, suggesting that it was
bound to membranes [22]. The actual kinase(s) responsible
for the phosphorylation of CaM in brain tissue was not
identiﬁed although it was suggested that CK-II could be
implicated [22]. Thereafter, it was demonstrated that the
phosphorylation sites of CaM in vivo, as isolated from rat
liver, where Thr79, Ser81 and Ser101, which correspond to
three of the four sites phosphorylated by CK-II in vitro,
suggesting that this kinase may be involved in the
phosphorylation of CaM in intact tissues [30]. Likewise, it
was estimated that approximately 15% of CaM present in
liver was in its phosphorylated form [30].
Calmodulin phosphorylated at serine and threonine
residues has been detected in normal nontransformed
ﬁbroblasts, while CaM isolated from cells transformed by
the Rous sarcoma virus presented phosphorylation at
serine, threonine plus tyrosine residues [60]. This suggests
that v-Src was responsible for the tyrosine-directed phos-
phorylation of CaM in physiological conditions [60].
The ﬁrst indication that physiological concentrations of
insulin stimulate the phosphorylation of CaM in intact cells,
presumably at tyrosine residues, was demonstrated in
adipocytes [67]. This report was challenged by other authors
who argued that the identiﬁed phosphoprotein was not
P-CaM [68]. They indicated that the misidentiﬁed protein
was phosphorylated by a protein-serine/threonine kinase
and that insulin does not stimulate the phosphorylation of
genuine CaM [68]. Nevertheless, subsequent reports further
demonstrated both the presence of P-CaM in isolated
hepatocytes and the existence of insulin-stimulated phos-
phorylation of CaM at serine, threonine plus tyrosine
residues in intact cells with an stoichiometry close to 0.5
(mol/mol) [30,69]. Using baculovirus-transfected cells
expressing the cytosolic domain of the b-subunit of the
InsR it was demonstrated that this receptor was directly
involved in the phosphorylation of CaM at both Tyr99 and
Tyr138 [31] (Table 1 and Fig. 1). The insulin-stimulated
phosphorylation of serine/threonine residues of CaM in
intact cells was proposed to be due, at least in part, to the
action of CK-II, an insulin-sensitive protein kinase
[29,31,69].
The activation of G protein-coupled receptors, such as
bradykinin receptors, generate signalling eventsmediated by
Jak2. During this process, it was demonstrated in intact
kidney cells the assembly of this protein-tyrosine kinase with
CaM and NHE1. The formation of this molecular complex
results in the subsequent phosphorylation of CaM at
tyrosine residues and the increased alkalinization of the
cytosol mediated by this antiporter [63].
D E P H O S P H O R Y L A T I O N O F
P H O S P H O C A L M O D U L I N
Although P-CaM is very prone to dephosphorylation in vivo
[21], little information is available on the actual protein
phosphatases involved in the dephosphorylation of the
different forms of P-CaM. Nevertheless, P-(Ser/Thr)-CaM,
as phosphorylated by CK-II, has been shown to be
dephosphorylated, albeit with low efﬁciency, by the pleio-
tropic phosphatases PP1c and PP2A. No evidence for
dephosphorylation of P-(Ser/Thr)-CaM by calcineurin
(PP2B) was found [33]. Up to day, the phosphotyrosine-
speciﬁc phosphatase(s) involved in the dephosphorylation
of P-(Tyr)-CaM has not been identiﬁed.
F U N C T I O N A L I M P L I C A T I O N S F O R T H E
D I F F E R E N T I A L M O D U L A T I O N
O F C A L M O D U L I N - D E P E N D E N T
S Y S T E M S B Y C A L M O D U L I N A N D
P H O S P H O C A L M O D U L I N
The effects of different species of CaM phosphorylated at
serine/threonine and/or tyrosine residues on the multiple
CaM-dependent systems of the cell have been explored to a
limited extent. Nevertheless, several enzymes, transport
systems and receptors have been studied, although most of
those works were performed in vitro (Table 2).
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Table 2. Action of phosphocalmodulin on calmodulin-dependent systems. The action and kinetics parameters of diﬀerent P-CaM species on diverse
CaM-dependent systems are indicated. When the phosphorylated amino acids in CaM is not shown the protein kinase involved in the phos-
phorylation of CaM is indicated in parenthesis (Table 1). P-(Tyr99)-CaM was puriﬁed from a preparation containing other P-CaM species as
phosphorylated by spleen PTK-III [62].
System P-CaM species (kinase) Action References
PDE1 (brain) P-(Ser/Thr)-CaM Threefold to ﬁvefold higher Kact [33,70,71]
(CK-II) and similar Vmax than CaM
PDE1 (brain) dans-P-(Ser/Thr)-CaM 21-Fold higher Kd than [71]
(CK-II) dans-CaM for CaM-BD
peptide
PDE1 (brain) P-(Tyr)-CaM Twofold higher Kact and [49]
(InsR) similar Vmax than CaM
PDE1 (brain) P-(Tyr99)-CaM Twofold lower Kact and [62]
similar Vmax than CaM,
ﬁvefold lower Kd than
CaM for a CaM-BD
peptide
PDE1 (liver) P-(Tyr)-CaM Similar Kact and Vmax [50]
(InsR) than CaM
PDE1 (heart) P-(Tyr)-CaM 90% inactive [57]
(EGFR)
AdeCycl P-(Tyr99)-CaM Ninefold lower Kd than CaM [62]
for a CaM-BD peptide
Ca2+-ATPase P-(Ser/Thr)-CaM Similar Kact and twofold [33]
(CK-II) lower Vmax than CaM
Ca 2+-ATPase P-(Ser/Thr)-CaM Two to threefold higher Kact and [33,71,72]
(CK-II) similar Vmax than CaM,
1.5-fold to twofold higher Kd than
CaM for dans-CaM-BD peptides
Ca 2+-ATPase P-(Tyr)-CaM Similar Kact and Vmax [72]
(InsR) than CaM
Ca 2+-ATPase P-(Tyr99)-CaM Threefold lower Kact and [62]
similar Vmax than CaM,
lower Kd than CaM for a
CaM-BD peptide
CaMPK-II P-(Ser/Thr)-CaM Two to threefold higher Kact [71,74]
(CK-II) and 10% to 5-fold lower Vmax
than CaM, 8-fold higher Kd
than CaM for a CaM-BD peptide
CaMPK-II dans-P-(Ser/Thr)-CaM Threefold lower Kd than [71]
(CK-II) dans-CaM for CaM-BD peptide
CaMPK-II P-(Tyr)-CaM Similar Kact and 30% [74]
(InsR) higher Vmax than CaM,
similar Kd than CaM for a
CaM-BD peptide
CaMPK-II P-(Tyr99)-CaM 1.5-Fold lower Kact and [62]
15% lower Vmax than CaM,
200-fold lower Kd than
CaM for a CaM-BD
peptide
MLCK P-(Thr)-CaM Similar Kact and Vmax [34]
(MLCK) than CaM
MLCK P-(Ser/Thr)-CaM Inactive, 30% inhibition [70]
(CK-II) basal activity
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Cyclic nucleotide phosphodiesterase
Calmodulin phosphorylated by CK-II has lower afﬁnity for
bovine brain PDE1 as compared with nonphosphorylated
CaM, although no differences were found on the Vmax or
the afﬁnity of the enzyme for Ca2+ [33,70,71]. In agreement
with these observations, the afﬁnity of dansylated P-(Ser/
Thr)-CaM for a peptide corresponding to the CaM-binding
site of this PDE1 was lower than its afﬁnity for dansylated
nonphosphorylated CaM [71]. Moreover, this phosphory-
lation decreased the stoichiometry from two peptides bound
per CaM molecule to only one [71] (Table 2).
The action of P-(Tyr)-CaM on PDE1 appears to vary
depending on the number of phosphorylated tyrosine
residues and the origin of the enzyme. Moreover, it should
be considered the variable proportion of P-CaM and native
CaM present in the different preparations used, as not
always P-CaM was free of its nonphosphorylated form.
CaM phosphorylated at Tyr99 plus Tyr138 by the InsR has
lower afﬁnity for bovine brain PDE1 than its nonphos-
phorylated counterpart [49]. In contrast, puriﬁed P-(Tyr99)-
CaM has comparatively higher afﬁnity for this enzyme than
nonphosphorylated CaM, and a peptide corresponding to
the CaM-binding site of PDE1 appears to have higher
afﬁnity for P-(Tyr99)-CaM that for its nonphosphorylated
form [62]. In both instances, no changes on the Vmax of the
enzyme were observed when nonphosphorylated CaM was
compared with the two P-(Tyr)-CaM species mentioned
above [49,62]. CaM phosphorylated by the InsR does not
show any differential effect as compared to nonphosphor-
ylated CaM when acting on a PDE1 isolated from rat
hepatocytes [50], while a preparation of P-(Tyr)-CaM, as
phosphorylated by the EGFR, and totally free of nonphos-
phorylated CaM,was unable to signiﬁcantly activate bovine
heart PDE1 [57] (Table 2).
Another interesting observation is that the phosphoryla-
tion of CaM by the InsR alters its interaction with different
CaM inhibitors [49,50]. Hence, by monitoring the PDE1
activity it was shown that P-(Tyr)-CaM was inhibited by
TFP and W7 less efﬁciently than CaM [50], while masto-
paran, another CaM inhibitor, increased its inhibitory
potential toward P-(Tyr)-CaM as compared to nonphos-
phorylated CaM [49].
Overall, the above mentioned observations suggest that
the action of the diverse P-(Ser/Thr)-CaM and P-(Tyr)-
CaM species, as produced by different kinases, could be
highly distinct in the different tissues, as it could either
increase or decrease the amount of cAMP and cGMP
available in the cell depending on the sensitivity of the PDE1
isoform to P-CaM.
Table 2. Continued.
System P-CaM species (kinase) Action References
MLCK dans-P-(Ser/Thr)-CaM More than sixfold higher [71]
(CK-II) Kd than dans-CaM
EGFR P-(Tyr)-CaM Twofold to threefold higher [52,53,55,59,75]
(EGFR) tyrosine kinase activity while
CaM inhibits
PP2B P-(Ser/Thr)-CaM Similar Kact and Vmax [74]
(CK-II) than CaM
PP2B P-(Ser/Thr)-CaM Sixfold higher Kact and [33,71]
(CK-II) similar Vmax than CaM,
15% lower Kd than CaM
for a CaM-BD peptide
PP2B P-(Tyr)-CaM Similar Kact and Vmax [74]
(InsR) than CaM
PP2B P-(Tyr99)-CaM Similar Kact and Vmax [62]
than CaM, 18-fold lower
Kd than CaM for CaM-BD
peptide
NOS P-(Ser/Thr)-CaM Twofold higher Kact and [33,71]
(CK-II) 2.6-fold higher Vmax than CaM
NOS dans-P-(Ser/Thr)-CaM Threefold higher Kd than [71]
(CK-II) dans-CaM for CaM-BD
peptide
NOS P-(Tyr99)-CaM Twofold higher Kact and [62]
3.4-fold higher Vmax than CaM,
fourfold lower Kd than CaM for
CaM-BD peptide
NHE1 P-(Tyr)-CaM Activation [63]
(Jak2)
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Adenylate cyclase
The only information available on the possible effect of
different P-CaM species on adenylate cyclase is that puriﬁed
P-(Tyr99)-CaM has signiﬁcant higher afﬁnity than non-
phosphorylated CaM for a peptide corresponding to the
CaM-binding domain of this enzyme [62] (Table 2). As the
action of this phosphorylated form of CaM on the activity
of the enzyme has not been tested, it is not possible to
predict its function.
Plasma membrane Ca2+-ATPase
Calmodulin phosphorylated by CK-II has a diminished
ability to activate the plasmamembrane Ca2+-ATPase. In a
ﬁrst report it was shown that the Vmax of the enzyme
decreased in the presence of P-(Ser/Thr)-CaM, while only a
marginal effect on its afﬁnity was detected [30]. Thereafter, it
was reported that P-(Ser/Thr)-CaM had lower afﬁnity than
nonphosphorylated CaM for the Ca2+-ATPase, and that
theVmax of the enzymewas not signiﬁcantly affected [30,72].
The discrepancy between those reports could be due to
differences in the phosphorylation extent of serine and
threonine residues. Moreover, the binding of CaM phos-
phorylated by CK-II to two synthetic peptides correspond-
ing to theCaM-binding domain of theCa2+-ATPase occurs
with slightly lower afﬁnity than that of nonphosphorylated
CaM [71], supporting the results on the impaired activation
of the Ca2+-ATPase activity described above (Table 2).
Concerning the effect of CaM phosphorylated by differ-
ent protein-tyrosine kinases, there are also conﬂicting
evidences. While some workers did not found any differ-
ences in the Vmax or the Kact of the Ca
2+-ATPase, or in the
afﬁnity of the enzyme for Ca2+, when CaM and P-(Tyr)-
CaM where compared [72], similar Vmax and an increase in
the afﬁnity of P-(Tyr99)-CaM for the Ca2+-ATPase, when
compared with native CaM, was observed by other group
[62]. An apparent difference among those experiments were
the species of P-CaM tested. While some investigators used
CaM phosphorylated by the cytosolic domain of the
b subunit of the insulin receptor with not further fraction-
ation [72], that it was shown to be phosphorylated at both
Tyr99 and Tyr138 [31,39,49]; others used PTK-III (a
mixture of c-Fyn and c-Fgr) from spleen to phosphorylate
CaM and puriﬁed the CaM species exclusively phosphory-
lated at Tyr99 for its assay [62]. The binding of P-(Tyr99)-
CaM to a synthetic peptide corresponding to the
CaM-binding domain of the Ca2+-ATPase showed higher
afﬁnity than that of nonphosphorylated CaM [62].
However, the binding of P-(Tyr99)-CaM to the same
dansylated peptide showed lower afﬁnity than native CaM
[62] (Table 2).
Using site-directed mutagenesis it was demonstrated that
CaM with a Tyr138Phe substitution has lower afﬁnity for
the Ca2+-ATPase than native CaM [72]. The phosphory-
lation at Tyr99 of this mutant CaM increased its afﬁnity for
the Ca2+-ATPase, approaching to values closer to those of
nonphosphorylated wild type CaM [72]. The Ca2+-ATPase
presented identical Vmax and afﬁnity for phosphorylated
and nonphosphorylatedwheat germCaM,which contains a
single tyrosine residue at position 139, albeit the Kact for
plant CaMwas fourfold higher than for nonphosphorylated
mammalian CaM [72].
The kinetics parameters for Ca2+ transport by the
plasma membrane Ca2+-ATPase have not yet been studied
in the presence of CaM phosphorylated at serine/threonine
or tyrosine residues, so it remains to be elucidated if these
phosphorylations are able to modify the efﬁciency of Ca2+
removal from the cytosol under physiological conditions. In
this context, it was demonstrated that physiological con-
centrations of insulin inhibited the Ca2+-ATPase activity
from isolated adipocyte plasma membranes [73], suggesting
that phosphorylation of CaM could be responsible for this
effect [37]. It is interesting to mention that the insulin-
sensitive CK-II could be involved in the process, as P-(Ser/
Thr)-CaM is known to affect the kinetics parameters of the
Ca2+-ATPase more dramatically than P-(Tyr)-CaM
[30,33,71,72] (Table 2).
Calmodulin-dependent protein kinase II
Calmodulin phosphorylated by CK-II has a decreased
ability to activate CaMPK-II because a diminished afﬁnity
for this enzyme. It also slightly decreased its Vmax and its
afﬁnity for Ca2+ [74]. On the contrary, CaM phosphoryl-
ated by the InsR increased the Vmax of CaMPK-II without
affecting other kinetics parameters [74], while puriﬁed
P-(Tyr99)-CaM slightly decreased the Vmax of this enzyme
[62] (Table 2). Therefore, it is expected than this kinase
could work less efﬁciently in the presence of P-(Ser/Thr)-
CaM, and with higher efﬁciency in the presence of P-(Tyr)-
CaM, as phosphorylated by the insulin receptor.
Surface plasmon resonance studies demonstrated that
phosphorylation of CaM by CK-II, but not by the InsR,
produced a decreased afﬁnity for a peptide corresponding
to the CaM-binding domain of CaMPK-II [74]. Other
binding studies using different techniques demonstrated
that a peptide corresponding to the CaM-binding site
of CaMPK-II has several order of magnitude higher
afﬁnity for puriﬁed P-(Tyr99)-CaM than for nonphos-
phorylated CaM [62]. Also, dansylated P-(Ser/Thr)-CaM,
as phosphorylated by CK-II, has higher afﬁnity than
dansylated nonphosphorylated CaM for a peptide corres-
ponding to the CaM-binding domain of CaMPK-II [71]
(Table 2).
Myosin light-chain kinase
Calmodulin phosphorylated by MLCK does not have a
differential effect as compared to nonphosphorylated
CaM on the activity of this kinase [34]. In contrast,
CaM phosphorylated by CK-II not only fails to activate
MLCK but also slightly inhibits its basal activity as
measured in the absence of CaM, as compared to assays
with nonphosphorylated CaM [70] (Table 2). This kinase
maintains the same afﬁnity for Ca2+ when assayed with
phosphorylated and nonphosphorylated CaM [70]. These
experiments demonstrate that the site of phosphorylation
of CaM is a critical factor that affects the activity of
MLCK, as CK-II and MLCK itself target different
residues in CaM (Table 1). Interestingly, titration experi-
ments show that the interaction of dansylated CaM with a
peptide corresponding to the CaM-binding site of MLCK
has a sigmoidal behaviour allowing for two peptides
bound per each dansylated CaM molecule [71]. In
contrast, the interaction of this peptide with dansylated
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P-CaM, as phosphorylated by CK-II, has a lower afﬁnity
and an hyperbolic behaviour, suggesting the existence of a
single binding site in this instance [71] (Table 2). CaM
phosphorylated by CK-II was equally sensitive to TFP
than nonphosphorylated CaM when assayed on the
MLCK activity [34].
Epidermal growth factor receptor
The effect of CaM phosphorylated by the EGFR on the
tyrosine kinase activity of this receptor has been studied
in a preliminary manner. The results indicate that this
P-(Tyr)-CaM species could be an activator of the
tyrosine kinase activity of the receptor both in the
presence and absence of Ca2+ [53,59,75], while
nonphosphorylated CaM has an inhibitory effect only
in the presence of Ca2+ [52,55] (Table 2). The space-
temporal phases on which CaM and P-(Tyr)-CaM
interact with the EGFR in intact cells have not yet
been identiﬁed. Therefore, it is not possible at present to
give a detailed description of the putative physiological
functions of this process. Nevertheless, we have proposed
that nonphosphorylated CaM could play a role on
receptor internalization and intracellular processing [76].
This has received experimental support in intact cells, as
permeant calmodulin inhibitors favour the accumulation
of the EGFR in endosomes preventing both its migra-
tion to lysosomes and its recycling back to the cell
surface [77].
Calcineurin
In a preliminary report it was shown that CaM phosphor-
ylated by CK-II does not modify the kinetics parameters of
calcineurin (PP2B) [74]. Thereafter, it was reported that
CaM phosphorylated by this kinase has less afﬁnity for
calcineurin than nonphosphorylated CaM, although this
enzyme has the same Vmax for both CaM species [33,71].
Nevertheless, this phosphorylation slightly increases the
afﬁnity of CaM for a peptide corresponding to the CaM-
binding site of calcineurin [71] (Table 2).
Phosphorylation of CaM by the InsR or PTK-III does
not signiﬁcantly affect the kinetics parameters of calcineurin
[62,74], although the afﬁnity of a peptide corresponding to
the CaM-binding site of this phosphatase was signiﬁcantly
higher for puriﬁed P-(Tyr99)-CaM than for nonphosphory-
lated CaM [62] (Table 2).
Nitric oxide synthase
The effect of P-CaM on NOS isolated from brain has been
investigated, and it was shown that both P-(Ser/Thr)-CaM
and P-(Tyr)-CaM species stimulated the enzyme to a larger
extent than nonphosphorylated CaM, and the afﬁnity of
both P-CaM species decreased with respect to its nonphos-
phorylated form [33,62,71]. It is interesting to mention that
themagnitudeof the increase in theactivityofNOSmediated
by phosphorylated CaM was far larger than the effects
observed on other CaM-dependent enzymes (Table 2).
Displacement experiments of a dansylated synthetic
peptide corresponding to the CaM-binding domain of
the plasma membrane Ca2+-ATPase bound to nonphos-
phorylated CaM or P-(Tyr99)-CaM by a peptide corres-
ponding to the CaM-binding domains of NOS were
performed in order to study the change in afﬁnity due to
this particular phosphorylation [62]. The results showed that
the afﬁnity of P-(Tyr99)-CaM for the CaM-binding site of
NOS increased with respect to nonphosphorylated CaM
[62], in agreement with the observed increase in activity.
However, titration of dansylated CaM and dansylated
P-(Ser/Thr)-CaM, as phosphorylated by CK-II, with a
peptide corresponding to theCaM-binding domain ofNOS,
showed that this peptide has lower afﬁnity for the
phosphorylated form of CaM than for its nonphosphoryl-
ated counterpart [71] (Table 2).
Na+/H+ exchanger
Calmodulin binds to NHE1 in a Ca2+-dependent manner,
inducing at least in part its activation and the subsequent
alkalinization of the cytosol [78]. It has been proposed that
CaM phosphorylation by Jak2 is enhanced by the ensuing
calcium signal generated by the activation of bradykinin B2
receptors, and that P-(Tyr)-CaM could act as a potent
activator of NHE1 by increasing its interaction with either
of its two CaM-binding domains [63] (Table 2). As the
EGFR also phosphorylates CaM (see above), this work
raises an interesting possibility; as the mitogenic activation
of cells via the EGFR and other growth factor receptors
also results in the activation of the Na+/H+ exchanger.
Hence, it is possible that P-(Tyr)-CaM generated during the
activation of the EGFR could contribute to the production
of the transient cytosolic alkalinization associated to the
mitogenic activation of cells by EGF.
C O N C L U D I N G R E M A R K S A N D
P R O S P E C T S
As we have learned from the different sections of this review
article, the phosphorylation of CaM appears to be a
widespread process leading to the regulation of diverse
cellular functions.Calmodulinmost frequentlymodulates its
activity by the availability of Ca2+, decoding in this manner
signals generated by extracellular and intracellular stimuli. It
is frequently noticed that Ca2+/CaM-dependent enzymes,
which play opposite physiological roles, exist in the cell.
Among these, protein kinases and phosphatases such as
CaMPK-II and calcineurin, and enzymes involved in the
synthesis and degradation of cyclic nucleotides such as
adenylate cyclase and PDE1, are relevant examples. It is
apparent that effective mechanisms must be in place to
prevent that these enzymes are equally activateduponarrival
of a suitable Ca2+ signal. Certainly, the subcellular com-
partmentation of the conﬂicting enzymes, and/or the exist-
ence of kinetics control able to differentially discern minute
changes in Ca2+ concentration, and therefore the frequency
and amplitude of its oscillations, could avoid the operation
of these futile regulatory cycles. Nevertheless, the efﬁciency
of this process is expected to be tighter if additional
regulatory systems were operative in the cell. CaM phos-
phorylation could play this role as an additional mechanism
entrusted in the physiology of this modulator to achieve the
ﬁne-tuning of the multiple CaM-dependent systems of the
cell independently of the generated Ca2+ signal.
The combinatorial phosphorylation of CaM at serine,
threonine and/or tyrosine residues opens the possibility that
3628 G. Benaim and A. Villalobo (Eur. J. Biochem. 269)  FEBS 2002
this Ca2+ sensor could have a variety of phosphorylated
species with distinct properties in intact cells. This area of
research is particularly interesting, as the assorted phos-
phorylation of CaM, that undoubtedly occurs in physio-
logical conditions, could contribute to explain the
plasticity and pleiotropicity shown by this modulator
when acting on the multiple CaM-dependent systems of
the cell. It is relevant to mention, that the information on
the action of P-CaM on their different targets is still very
limited (Table 2). Therefore, it is expected that additional
CaM-dependent proteins would be added to the list of
systems that are differentially modulated by CaM and
P-CaM. Likewise, P-CaM is also expected to play
additional, but yet unknown, roles on CaM-dependent
systems on which the interaction between modulator and
target occurs in the absence of Ca2+. Therefore, future
work in this unexplored area may help to unravel new
physiological functions of apocalmodulin. It would also be
important to have an outlook on whether P-(Tyr)-CaM is
a distinct signalling molecule able to target proteins
containing SH2 and/or PTB domains thereby affecting
their functions.
The great majority of reported experiments have shown
that it is required the presence of positively charged
cofactors for the efﬁcient phosphorylation of CaM. This is
so for virtually all protein kinases tested, and it is possible
that unnoticed basic proteins or other cationic contaminants
could be present in the few examples where CaM phos-
phorylation was observed in the absence of added polyca-
tions. Thus, another interesting point that requires special
attention is to establish the nature of the physiological
ligand(s) that acts as cofactor(s) for CaM phosphorylation
in intact cells, as this topic is largely neglected.Most workers
have used in their experiments a series of synthetic
polycations or basic proteins, such as histones, that may
not have relevance for the phosphorylation of CaM in a
physiological setting. Recently, a striking and disconcerting
observations have been performed on the location of the
EGFR and ErbB4 receptor in the nucleus and their putative
role as transcription factors [79,80]. As the much needed
conﬁrmation of these unexpected observations unfolds, the
possibility that CaMcould be phosphorylated at the nucleus
by these receptors or other protein kinases known to have
nuclear location using histones as physiological cofactors is
open to debate. The case for the EGFR is particularly
interesting, as the NLS proposed to be involved in the
translocation process [79], has been previously shown by
our group to be the Ca2+-dependent CaM-binding domain
of this receptor located at its cytosolic juxtamembrane
region [76]. A similar consensus NLS has been proposed to
exist, among others, in the cytosolic juxtamembrane region
of the ErbB4 receptor [81].
An additional problem which requires to be addressed in
order to understand the role of the different P-CaM species
in the cell is the identiﬁcation of the whole set of protein
kinases and phophoprotein phosphatases involved in the
phosphorylation/dephosphorylation cycle of CaM in dif-
ferent tissues and under diverse developmental and physio-
logical conditions. The panoply of enzymes involved in
these processes in distinct organisms is expected to be large.
Hence, it is expected that the progress of proteomic projects
in a variety of living species, including human, may help to
uncover new enzymes involved in physiologically relevant
phosphorylation and dephosphorylation events of CaM in
intact cells.
Finally, a signiﬁcant effort must be made to determine all
relevant physiological functions that the diverse sets of
P-CaM species present in the cell may have at a given time.
To this end, the use of transfectants that could express in an
inducible manner dominant-negative CaM mutants unable
to be phosphorylated by speciﬁc protein kinases could be of
help.
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